Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Serina Therapeutics (SER) Times Interest Earned (2021 - 2025)

Serina Therapeutics' Times Interest Earned history spans 5 years, with the latest figure at -$1065.3 for Q3 2025.

  • For Q3 2025, Times Interest Earned fell 220.88% year-over-year to -$1065.3; the TTM value through Sep 2025 reached -$730.12, down 34361.21%, while the annual FY2024 figure was -$32.41, 477.98% down from the prior year.
  • Times Interest Earned for Q3 2025 was -$1065.3 at Serina Therapeutics, down from -$618.33 in the prior quarter.
  • Across five years, Times Interest Earned topped out at -$0.75 in Q4 2023 and bottomed at -$1065.3 in Q3 2025.
  • The 5-year median for Times Interest Earned is -$11.19 (2023), against an average of -$161.15.
  • The largest annual shift saw Times Interest Earned skyrocketed 71.41% in 2022 before it plummeted 43508.05% in 2024.
  • A 5-year view of Times Interest Earned shows it stood at -$5.87 in 2021, then soared by 68.98% to -$1.82 in 2022, then surged by 58.92% to -$0.75 in 2023, then tumbled by 43508.05% to -$326.41 in 2024, then crashed by 226.38% to -$1065.3 in 2025.
  • Per Business Quant, the three most recent readings for SER's Times Interest Earned are -$1065.3 (Q3 2025), -$618.33 (Q2 2025), and -$326.41 (Q4 2024).